Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998

Watchlist Manager
Hunan Fangsheng Pharmaceutical Co Ltd Logo
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Watchlist
Price: 10.75 CNY 0.94%
Market Cap: 4.7B CNY
Have any thoughts about
Hunan Fangsheng Pharmaceutical Co Ltd?
Write Note

Hunan Fangsheng Pharmaceutical Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Hunan Fangsheng Pharmaceutical Co Ltd
Revenue Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Hunan Fangsheng Pharmaceutical Co Ltd
SSE:603998
Revenue
ÂĄ1.8B
CAGR 3-Years
6%
CAGR 5-Years
10%
CAGR 10-Years
16%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Revenue
ÂĄ10.1B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Revenue
ÂĄ10.9B
CAGR 3-Years
13%
CAGR 5-Years
15%
CAGR 10-Years
23%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Revenue
ÂĄ26B
CAGR 3-Years
-3%
CAGR 5-Years
3%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Revenue
ÂĄ39.3B
CAGR 3-Years
2%
CAGR 5-Years
7%
CAGR 10-Years
8%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Revenue
ÂĄ561.9m
CAGR 3-Years
-18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

Hunan Fangsheng Pharmaceutical Co Ltd
Glance View

Market Cap
4.7B CNY
Industry
Pharmaceuticals

Hunan Fangsheng Pharmaceutical Co., Ltd. engages in the manufacture, distribution, research and development of pharmaceutical products. The company is headquartered in Changsha, Hunan and currently employs 2,808 full-time employees. The company went IPO on 2014-12-05. The firm's main products include Xuesaitong Dispersible Tablets, Xuesaitong Tablets, Tenghuang Jiangu Tablets, Dieda Huoxue Capsules, Lysine Dimension B12 Granules, Cefixoxime Tablets and Jinying Capsules. The firm distributes its products primarily in domestic market.

Intrinsic Value
15 CNY
Undervaluation 28%
Intrinsic Value
Price

See Also

What is Hunan Fangsheng Pharmaceutical Co Ltd's Revenue?
Revenue
1.8B CNY

Based on the financial report for Sep 30, 2024, Hunan Fangsheng Pharmaceutical Co Ltd's Revenue amounts to 1.8B CNY.

What is Hunan Fangsheng Pharmaceutical Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
16%

Over the last year, the Revenue growth was 7%. The average annual Revenue growth rates for Hunan Fangsheng Pharmaceutical Co Ltd have been 6% over the past three years , 10% over the past five years , and 16% over the past ten years .

Back to Top